Bettina T Begay, SOCIAL WORKER | |
2 W 3rd St, Cibecue, AZ 85911 | |
(928) 332-2560 | |
Not Available |
Full Name | Bettina T Begay |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 2 W 3rd St, Cibecue, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962418517 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bettina T Begay, SOCIAL WORKER Po Box 80039, Cibecue, AZ 85911-0039 Ph: (928) 332-2560 | Bettina T Begay, SOCIAL WORKER 2 W 3rd St, Cibecue, AZ 85911 Ph: (928) 332-2560 |
News Archive
While a couple of glasses of wine can help clear the mind after a busy day, new research shows that it may actually help clean the mind as well.
Researchers need to proactively engage lesbian, gay, bisexual, and transgender people in health studies and collect data on these populations to identify and better understand health conditions that affect them, says a new report from the Institute of Medicine.
Closing a critical gap in knowledge, Harvard Medical School scientists have unraveled the immune cascade that fuels tissue damage and disease development in chlamydia infection-;the most common sexually transmitted disease in the United States.
Mayo Clinic researchers have discovered that a molecular communication pathway – thought to be defective in cancer – is a key player in determining the effectiveness of measles virus oncolytic cancer treatment in ovarian and aggressive brain cancers.
There are concerns regarding breast implants and the association with cancer. UP to 30,000 French women and perhaps tens of thousands more around the world may need to have defective breast implants removed after several suspicious cancer cases. The final decision on recall of the implants, produced by the Poly Implant Prothese (PIP) company will be made by the end of the week, after a report from France's National Cancer Institute on December 23.
› Verified 7 days ago